Clinical Cancer Research · 2004 · 109 citations · 23 references
MedicineMolecular BiologyOncologyMetastasisMolecular OncologyTumor ProgressionBiomarkers In Genitourinary CancerCancer ProteomicsMolecular Tumor ProfilingProstate CancerProstate PathologyProtein IdentificationCancer Metastasis BiomarkersConstitutive Expression SystemsConstitutive Gene ExpressionMatrix Metalloproteinase Gene ExpressionMatrix MetalloproteinasesProstate Cancer PrognosisProstate Carcinogenesis
PURPOSE: Id proteins are dominant-negative regulators of basic helix-loop-helix transcription factors that control malignant cell behavior in many different tissues. This study aimed to identify the potential role of Id-1 and Id-2 proteins as molecular makers for prostate cancer progression. EXPERIMENTAL DESIGN: Using the technique of immunohistochemistry, we determined Id-1 and Id-2 expression in a panel of 67 human prostate biopsies. We also manipulated Id-1 and Id-2 expression in LNCaP and PC3 prostate cancer cell lines and determined the effects on invasion in vitro, matrix metalloproteinase secretion, and proliferation. RESULTS: Both Id-1 and Id-2 proteins were up-regulated during human prostate cancer progression in vivo and were overexpressed in highly aggressive prostate cancer cells. In vitro, constitutive expression of Id-1, and to a lesser extent Id-2, converted nonaggressive LNCaP prostate cancer cells into more proliferative and invasive cells and increased their secretion of matrix metalloproteinases. Conversely, the down-regulation of Id-2 expression in highly metastatic PC3 cells reduced their growth potential and invasiveness. CONCLUSIONS: We propose that both Id-1 and Id-2 proteins control prostate cancer cell phenotypes and could serve as molecular markers of aggressive human prostate cancer.
23
Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts
David Lyden, Alison Z. Young, David Zagzag et al. · Nature · 1999 · 934 citations
Medicine, Cancer Biology, Oncology +12